• Maintain healthy immune system regulation.
• Reduce occurrence of, and manage, allergy symptoms.
• Decrease occurrence of eczema in infants and children. Eczema affects up to 1 in 3 children.
• Combination of two immune modulating, anti-inflammatory probiotic strains.
  

Clinical benefits:

• Lactobacillusrhamnosus LGG® and Lactobacillus paracasei (LP-33™) help to promoteimmune regulation by interacting with dendritic cells within the gutassociated lymphoid tissue (GALT) stimulating the production ofregulatory T cells and increasing production of regulatory cytokinessuch as IL-10 and TGF-beta.
• LGG® promotes a shift towards anenhanced anti-inflammatory response by a heightened secretion ofanti-inflammatory cytokines and decreased secrtion of pro-inflammatorycytokines.
• LGG® has bidirectional immunomodulatory effects -stimulatory when an increased response is needed and down-regulatorywhen attenuation is appropriate.
• LP-33™ modulates inflammationand immune reactions by interacting with these cells ans, together withLGG®, inducing development of regulatory T cells which can down regulateIgE, a Th2 cytokine involved in allergy.